zaprinast and Osteoporosis

zaprinast has been researched along with Osteoporosis* in 1 studies

Other Studies

1 other study(ies) available for zaprinast and Osteoporosis

Article	Year
Effects of the Phosphodiesterase-5 (PDE-5) Inhibitors, Avanafil and Zaprinast, on Bone Remodeling and Oxidative Damage in a Rat Model of Glucocorticoid-Induced Osteoporosis. Medical science monitor basic research, 2018, 03-13, Volume: 24 Topics: Animals; Bone Density; Bone Remodeling; Cyclic Nucleotide Phosphodiesterases, Type 5; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Glucocorticoids; Male; Osteoporosis; Oxidation-Reduction; Oxidative Stress; Phosphodiesterase 5 Inhibitors; Purinones; Pyrimidines; Rats	2018

Article

Year

Effects of the Phosphodiesterase-5 (PDE-5) Inhibitors, Avanafil and Zaprinast, on Bone Remodeling and Oxidative Damage in a Rat Model of Glucocorticoid-Induced Osteoporosis.

Medical science monitor basic research, 2018, 03-13, Volume: 24

Topics: Animals; Bone Density; Bone Remodeling; Cyclic Nucleotide Phosphodiesterases, Type 5; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Glucocorticoids; Male; Osteoporosis; Oxidation-Reduction; Oxidative Stress; Phosphodiesterase 5 Inhibitors; Purinones; Pyrimidines; Rats

2018